Cyanvac

0 followers

‌

Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.

Industries

Biotechnology, Health Care

Headquarters

Athens, United States

Links

Org chart

Fred C. Davison

Chief Executive Officer

Collapse

Gary Titus

Chief Financial Officer

Hong Jin

Chief Scientific Officer

Marinka Tellier

Chief Regulatory Affairs Officer

Samuel Wu

Chief Business Officer

Teams

This company has no teams yet

Offices

HQ
0 people · 0 jobs

AtriCure

4 followers

Merck

329 followers

AbbVie

327 followers

Abbott

435 followers

Amgen

321 followers

Agiliti

8 followers

Elanco

30 followers

Taiho Oncology, Inc.

3 followers

Revvity

12 followers

DM Clinical Research

18 followers

Bristol-Myers Squibb

294 followers

Cyanvac

Org chart

Teams

Offices

Related companies